The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Open accessAbstract
The oral route is a preferred method of drug administration, though achieving effective drug delivery and minimizing off-target side effects is often challenging. Formulation into nanoparticles can improve drug stability in the harsh gastrointestinal (GI) tract environment, providing opportunities for targeting specific sites in the GI tract, increasing drug solubility and bioavailability, and providing sustained release in the GI tract. However, the unique and diverse physiology throughout the GI tract, including wide variation in pH, mucus that varies in thickness and structure, numerous cell types, and various physiological functions are both a barrier to effective delivery and an opportunity for nanoparticle design. Here, nanoparticle design aspects to improve delivery to particular sites in the GI tract are discussed. We then review new methods for evaluating oral nanoparticle formulations, including a short commentary on data interpretation and translation. Finally, the state-of-the-art in preclinical targeted nanoparticle design is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review
George, M., & Abraham, T. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.017 · Cited by 2,012
From 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Self-citationKim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Self-citationKararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Johansson, M. E. V., Larsson, J. M. H., & Hansson, G. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006451107 · Cited by 1,452
How informative is the mouse for human gut microbiota research?
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334 · cited 1×
“Murine colitis models show similar alterations in the colonic microflora as found in human IBD studies [91].”
ResultNanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Micro- and macrorheology of mucus
Lai, S. K., Wang, Y.-Y., Wirtz, D., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.012 · Cited by 1,223
Self-citationRapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Self-citationJohansson, M. E. V., Gustafsson, J. K., Holmén-Larsson, J., Jabbar, K. S., Xia, L., Xu, H., Ghishan, F. K., Carvalho, F. A., Gewirtz, A. T., Sjövall, H., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303207 · Cited by 1,004
Modelling human development and disease in pluripotent stem-cell-derived gastric organoids
McCracken, K. W., Catá, E. M., Crawford, C. M., Sinagoga, K. L., Schumacher, M., Rockich, B. E., Tsai, Y.-H., Mayhew, C. N., Spence, J. R., Zavros, Y., et al. (2014) · Nature · doi:10.1038/nature13863 · Cited by 980 · cited 1×
“Recent reports include: the work of Grabinger and coworkers toward generation of ex vivo cultures of intestinal crypt organoids and methods for monitoring and scoring organoid survival and death [123]; the work of McCracken and coworkers toward generating pluripotent stem-cell-derived gastric organoids that include ga…”
BackgroundKim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
Kim, H. J., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40126j · Cited by 750
The composition of the gut microbiota shapes the colon mucus barrier
Jakobsson, H. E., Rodríguez‐Piñeiro, A. M., Schütte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Bäckhed, F., Hansson, G. C., & Johansson, M. E. (2015) · The EMBO Reports · doi:10.15252/embr.201439263 · Cited by 700
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Disintegration of Solid Foods in Human Stomach
Kong, F., & Singh, R. P. (2008) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.00766.x · Cited by 598
Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract
Powell, J. J., Faria, N., Thomas-McKay, E., & Pele, L. C. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.006 · Cited by 543
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
Lih-Brody, L., Powell, S. R., Collier, K. P., Reddy, G. M., Cerchia, R., Kahn, E., Weissman, G. S., Katz, S., Floyd, R. A., McKinley, M. J., et al. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093613 · Cited by 496
Hua, S., Marks, E., Schneider, J. J., & Keely, S. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.02.018 · Cited by 494
Eudragit®: a technology evaluation
Thakral, S., Thakral, N. K., & Majumdar, D. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.736962 · Cited by 458
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Intestinal barrier function and absorption in pigs after weaning: a review
Wijtten, P. J. A., Meulen, J. V. D., & Verstegen, M. W. A. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510005660 · Cited by 443
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Gastroretentive dosage forms: Overview and special case of Helicobacter pylori
Bardonnet, P. L., Faivre, V., Pugh, W. J., Piffaretti, J. C., & Falson, F. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.031 · Cited by 415
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
In vitro models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Abrahamsson, B., Brewster, M., Brouwers, J., Butler, J., Carlert, S., Dickinson, P. A., Dressman, J., Holm, R., Klein, S., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.024 · Cited by 373
ABSORPTION OF DRUGS FROM THE RAT SMALL INTESTINE
Schanker, L. S., Tocco, D. J., Brodie, B. B., & Hogben, C. A. M. (1958) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12018-1 · Cited by 371
pH- and ion-sensitive polymers for drug delivery
Yoshida, T., Lai, T. C., Kwon, G. S., & Sako, K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.821978 · Cited by 367
Cho, W.-S., Kang, B.-C., Lee, J. K., Jeong, J., Che, J.-H., & Seok, S. H. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-9 · Cited by 361
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
Darwis, Y., Ali Khan, A., Mudassir, J., & Mohtar, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41521 · Cited by 333
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Self-citationMicrobially triggered drug delivery to the colon
Sinha, V. R., & Kumria, R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00221-x · Cited by 316
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
des Rieux, A., Fievez, V., Théate, I., Mast, J., Préat, V., & Schneider, Y.-J. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.12.006 · Cited by 310
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
Self-citationMahler, G. J., Shuler, M. L., & Glahn, R. P. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.05.006 · Cited by 287
In vitro and in vivo models for the study of oral delivery of nanoparticles
Gamboa, J. M., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.003 · Cited by 285
Esch, M. B., Mahler, G. J., Stokol, T., & Shuler, M. L. (2014) · Lab Chip · doi:10.1039/c4lc00371c · Cited by 281 · cited 2×
“did not result in any measurable increase in cell permeability or cell death [129].”
BackgroundErah, P. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.1.5 · Cited by 275
Walter, E., Janich, S., Roessler, B. J., Hilfinger, J. M., & Amidon, G. L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960110x · Cited by 273
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges
Holmgren, J., Czerkinsky, C., Eriksson, K., & Mharandi, A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00206-8 · Cited by 260
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
Aji Alex, M. R., Chacko, A. J., Jose, S., & Souto, E. B. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.10.002 · Cited by 258
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Collnot, E.-M., Ali, H., & Lehr, C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.028 · Cited by 254
Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals
Puglia, C., & Bonina, F. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.666967 · Cited by 253
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Cai, S., Yang, Q., Bagby, T. R., & Forrest, M. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.017 · Cited by 252
The lectin–cell interaction and its implications to intestinal lectin-mediated drug delivery
Gabor, F., Bogner, E., Weissenboeck, A., & Wirth, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.015 · Cited by 247
Dysbiotic Events in Gut Microbiota: Impact on Human Health
Schippa, S., & Conte, M. (2014) · Nutrients · doi:10.3390/nu6125786 · Cited by 246
pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease
Beloqui, A., Coco, R., Memvanga, P. B., Ucakar, B., des Rieux, A., & Préat, V. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.009 · Cited by 240
Yuan, H., Chen, C.-Y., Chai, G.-H., Du, Y.-Z., & Hu, F.-Q. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300649z · Cited by 234
Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., Li, X., & Wang, F. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0889-z · Cited by 227
Leonard, F., Collnot, E.-M., & Lehr, C.-M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1000795 · Cited by 223
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Pappo, J., & Ermak, T. H. (1989) · PubMed Central · Cited by 216
Pusztai, A., Ewen, S. W. B., Grant, G., Peumans, W. J., van Damme, E. J. M., Rubio, L., & Bardocz, S. (1990) · Digestion · doi:10.1159/000200402 · Cited by 216
Animal versus human oral drug bioavailability: Do they correlate?
Musther, H., Olivares-Morales, A., Hatley, O. J. D., Liu, B., & Rostami Hodjegan, A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.018 · Cited by 211
Grabinger, T., Luks, L., Kostadinova, F., Zimberlin, C., Medema, J. P., Leist, M., & Brunner, T. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.183 · Cited by 210
Vong, L. B., Tomita, T., Yoshitomi, T., Matsui, H., & Nagasaki, Y. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.043 · Cited by 196
Raft forming system—An upcoming approach of gastroretentive drug delivery system
Prajapati, V. D., Jani, G. K., Khutliwala, T. A., & Zala, B. S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.028 · Cited by 192
Oral delivery of proteins by biodegradable nanoparticles
Bakhru, S. H., Furtado, S., Morello, A. P., & Mathiowitz, E. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.006 · Cited by 190
Wang, X.-Q., & Zhang, Q. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.07.014 · Cited by 189
Robust bioengineered 3D functional human intestinal epithelium
Chen, Y., Lin, Y., Davis, K. M., Wang, Q., Rnjak-Kovacina, J., Li, C., Isberg, R. R., Kumamoto, C. A., Mecsas, J., & Kaplan, D. L. (2015) · Scientific Reports · doi:10.1038/srep13708 · Cited by 185
Human enteroids as an ex-vivo model of host–pathogen interactions in the gastrointestinal tract
Foulke-Abel, J., In, J., Kovbasnjuk, O., Zachos, N. C., Ettayebi, K., Blutt, S. E., Hyser, J. M., Zeng, X.-L., Crawford, S. E., Broughman, J. R., et al. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214529398 · Cited by 179
Esch, M. B., Sung, J. H., Yang, J., Yu, C., Yu, J., March, J. C., & Shuler, M. L. (2012) · Biomedical Microdevices · doi:10.1007/s10544-012-9669-0 · Cited by 179
In vitro–in vivo correlation for complex non-oral drug products: Where do we stand?
Shen, J., & Burgess, D. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.052 · Cited by 177
Gastrointestinal Absorption of Intact Proteins
Gardner, M. L. G. (1988) · Annual Review of Nutrition · doi:10.1146/annurev.nu.08.070188.001553 · Cited by 176
Schimpel, C., Teubl, B., Absenger, M., Meindl, C., Fröhlich, E., Leitinger, G., Zimmer, A., & Roblegg, E. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400507g · Cited by 173
Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability
Sehnert, S. S. (2004) · PubMed Central · Cited by 170
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes
Jubeh, T. T., Barenholz, Y., & Rubinstein, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019298.29561.cd · Cited by 164
Laroui, H., Viennois, E., Xiao, B., Canup, B. S. B., Geem, D., Denning, T. L., & Merlin, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.046 · Cited by 163
Wikman-Larhed, A., & Artursson, P. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00007-z · Cited by 163
Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies
Coco, R., Plapied, L., Pourcelle, V., Jérôme, C., Brayden, D. J., Schneider, Y.-J., & Préat, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.017 · Cited by 162
Kim, D.-D., Cho, H.-J., Park, J. W., & Yoon, I.-S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s56648 · Cited by 162
Pawar, V. K., Meher, J. G., Singh, Y., Chaurasia, M., Reddy, B. S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.031 · Cited by 161
Abdulkarim, M., Agulló, N., Cattoz, B., Griffiths, P. C., Bernkop‐Schnürch, A., Borrós, S., & Gumbleton, M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.023 · Cited by 160
Zhang, Z., Gao, F., Bu, H., Xiao, J., & Li, Y. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.016 · Cited by 159
Malingré, M. M., Beijnen, J. H., & Schellens, J. H. M. (2001) · Investigational New Drugs · doi:10.1023/a:1010635000879 · Cited by 158
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination
Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.-L., Jerôme, C., Vanderplasschen, A., Marchand-Brynaert, J., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.009 · Cited by 158
Verma, A., Sharma, S., Gupta, P. K., Singh, A. K., Teja, B. V., Dwivedi, P., Gupta, G. K., Trivedi, R., & Mishra, P. R. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.017 · Cited by 153
Chang, C., Lin, Y.-H., Yeh, C., Chen, Y., Chiou, S.-F., Hsu, Y., Chen, Y.-S., & Wang, C.-C. (2009) · Biomacromolecules · doi:10.1021/bm900985h · Cited by 150
Progress and future of in vitro models to study translocation of nanoparticles
Braakhuis, H., Kloet, S. K., Kežić, S., Kuper, C. F., Park, M. V. D. Z., Bellmann, S., van der Zande, M., Gac, S. L., Krystek, P., Peters, R., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1518-5 · Cited by 149
Ali, H., Weigmann, B., Neurath, M. F., Collnot, E. M., Windbergs, M., & Lehr, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.039 · Cited by 149
Lefebvre, D. E., Venema, K., Gombau, L., Valerio, L. G., Raju, J., Bondy, G. S., Bouwmeester, H., Singh, R. P., Clippinger, A. J., Collnot, E.-M., et al. (2014) · Nanotoxicology · doi:10.3109/17435390.2014.948091 · Cited by 146
Suwannateep, N., Banlunara, W., Wanichwecharungruang, S. P., Chiablaem, K., Lirdprapamongkol, K., & Svasti, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.011 · Cited by 145
Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier
de Sousa, I. P., Cattoz, B., Wilcox, M. D., Griffiths, P. C., Dalgliesh, R. M., Rogers, S. E., & Bernkop‐Schnürch, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.008 · Cited by 145
Yıldız, H., McKelvey, C. A., Marsac, P. J., & Carrier, R. L. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1086359 · Cited by 143
Oral peptide and protein delivery: intestinal obstacles and commercial prospects
Smart, A. L., Gaisford, S., & Basit, A. W. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.917077 · Cited by 143
Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus
Dawson, M., Krauland, E. M., Wirtz, D., & Hanes, J. S. (2004) · Biotechnology Progress · doi:10.1021/bp0342553 · Cited by 142
Self-citationRavi, P. R., Aditya, N., Kathuria, H., Malekar, S., & Vats, R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.015 · Cited by 140
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
Bellmann, S., Carlander, D., Fasano, A., Momcilovic, D., Scimeca, J. A., Waldman, W. J., Gombau, L., Tsytsikova, L., Canady, R., Pereira, D. I. A., et al. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1333 · Cited by 137
Pastuła, A., Middelhoff, M. A., Brandtner, A. K., Tobiasch, M., Höhl, B., Nuber, A. H., Demir, İ. E., Neupert, S., Kollmann, P., Mazzuoli‐Weber, G., et al. (2015) · Stem Cells International · doi:10.1155/2016/3710836 · Cited by 136
Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption
Attili-Qadri, S., Karra, N., Nemirovski, A., Schwob, O., Talmon, Y., Nassar, T., & Benita, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313839110 · Cited by 135
Targeting to intestinal M cells.
Jepson, M. A., Clark, M. A., Foster, N. M., Mason, C. M., Bennett, M. K., Simmons, N. L., & Hirst, B. H. (1996) · Europe PMC (PubMed Central) · Cited by 133
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Lin, Y.-H., Tsai, S.-C., Lai, C., Lee, C., He, Z. S., & Tseng, G.-C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.028 · Cited by 126
Application of Method Suitability for Drug Permeability Classification
Volpe, D. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9227-8 · Cited by 124
Chia, S. L., Tay, C. Y., Setyawati, M. I., & Leong, D. T. (2014) · Small · doi:10.1002/smll.201401915 · Cited by 122
Zhang, J., Zhu, X., Jin, Y., Wei, S., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400685v · Cited by 122
Recent approaches of lipid-based delivery system for lymphatic targeting via oral route
Chaudhary, S., Garg, T., Murthy, R. S. R., Rath, G., & Goyal, A. K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.950664 · Cited by 120
Use of Azo Polymers for Colon-Specific Drug Delivery
den Mooter, G. V., Maris, B., Samyn, C., Augustijns, P., & Kinget, R. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9702630 · Cited by 119
Anatomy and Physiology of the Stomach
Soybel, D. I. (2005) · Surgical Clinics of North America · doi:10.1016/j.suc.2005.05.009 · Cited by 117
Compartmentalization of the gut viral reservoir in HIV-1 infected patients
van Marle, G., Gill, M. J., Kolodka, D., McManus, L., Grant, T. D., & Church, D. L. (2007) · Retrovirology · doi:10.1186/1742-4690-4-87 · Cited by 116
Micro/nanofabricated platforms for oral drug delivery
Fox, C. B., Kim, J., Le, L. V., Nemeth, C. L., Chirra, H. D., & Desai, T. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.033 · Cited by 114
Alternative functional in vitro models of human intestinal epithelia
Kauffman, A. L., Gyurdieva, A. V., Mabus, J. R., Ferguson, C., Yan, Z., & Hornby, P. J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00079 · Cited by 114
Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery
Hu, X., Fan, W., Yu, Z., Lü, Y., Qi, J., Zhang, J., Dong, X., Zhao, W., & Wu, W. (2015) · Nanoscale · doi:10.1039/c5nr07474f · Cited by 114
Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems
Patel, M. M., Shah, T. J., & Amin, A. F. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i2.20 · Cited by 108
Yoo, J., Naeem, M., Choi, M., Cao, J., Yoon, S., Kim, M., Jung, Y., Lee, J., Moon, H. R., Ikram, M., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s88672 · Cited by 108
Hunter, A. C., Elsom, J., Wibroe, P. P., & Moghimi, S. M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.07.005 · Cited by 108
Reineke, J., Cho, D., Dingle, Y. L., Morello, A. P., Jacob, J. S., Thanos, C. G., & Mathiowitz, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305882110 · Cited by 106
Sedghi, S., Fields, J. Z., Klamut, M., Urban, G., Durkin, M., Winship, D. H., Fretland, D. J., Olyaee, M. S., & Keshavarzian, A. (1993) · Gut · doi:10.1136/gut.34.9.1191 · Cited by 106
Ensign, L. M., Henning, A., Schneider, C. S., Maisel, K., Wang, Y.-Y., Porosoff, M. D., Cone, R. A., & Hanes, J. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400087y · Cited by 105
Self-citationDevelopment and in vivo evaluation of papain-functionalized nanoparticles
Muller, C. R., Perera, G., König, V., & Bernkop‐Schnürch, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.012 · Cited by 105
Vitamin B12in drug delivery: breaking through the barriers to a B12bioconjugate pharmaceutical
Clardy, S. M., Allis, D. G., Fairchild, T. J., & Doyle, R. P. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.539200 · Cited by 104
Vong, L. B., Yoshitomi, T., Matsui, H., & Nagasaki, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.037 · Cited by 104
Zou, T., & Gu, L. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400086n · Cited by 104
Liu, Q., Li, J., Pu, G., Zhang, F., Liu, H., & Zhang, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1031295 · Cited by 101
Tariq, M., Alam, A., Singh, A. T., Iqbal, Z., Panda, A. K., & Talegaonkar, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.02.043 · Cited by 98
Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon
Naeem, M., Kim, W., Cao, J., Jung, Y., & Yoo, J. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.026 · Cited by 98
A Comparison of Pharmacokinetics between Humans and Monkeys
Akabane, T., Tabata, K., Kadono, K., Sakuda, S., Terashita, S., & Teramura, T. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028829 · Cited by 97
Han, S., Quach, T., Hu, L., Wahab, A., Charman, W. N., Stella, V. J., Trevaskis, N. L., Simpson, J. S., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.031 · Cited by 97
Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis
Moulari, B., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.046 · Cited by 96
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases
Youshia, J., & Lamprecht, A. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1114604 · Cited by 95
Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery
Zhang, L., Sang, Y., Feng, J., Li, Z., & Zhao, A. (2016) · Journal of drug targeting · doi:10.3109/1061186x.2015.1128941 · Cited by 95
Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
Devriendt, B., Geest, B. G. D., Goddeeris, B. M., & Cox, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.006 · Cited by 94
Roles of M cells in infection and mucosal vaccines
Wang, M., Gao, Z., Zhang, Z., Pan, L., & Zhang, Y. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.36174 · Cited by 94
Gugulothu, D. B., Kulkarni, A., Patravale, V. B., & Dandekar, P. P. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23828 · Cited by 91
Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys?
Man, A., Prieto‐Garcia, M. E., & Nicoletti, C. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01964.x · Cited by 88
Navabi, N., Johansson, M., Raghavan, S., & Lindén, S. K. (2012) · Infection and Immunity · doi:10.1128/iai.01000-12 · Cited by 85
de LeBlanc, A. D. M., & Perdigón, G. (2005) · PubMed · Cited by 84
Lymphatic system: a prospective area for advanced targeting of particulate drug carriers
Singh, I., Swami, R., Khan, W., & Sistla, R. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866088 · Cited by 83
Shahbazi, M., & Santos, H. A. (2012) · Current Drug Metabolism · doi:10.2174/138920013804545133 · Cited by 82
Mucus permeating thiomer nanoparticles
Köllner, S., Dünnhaupt, S., Waldner, C., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.004 · Cited by 80
Ma, T., Wang, L., Yang, T., Ma, G., & Wang, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.06.052 · Cited by 80
KANG, S., WOO, J., KIM, M., et al. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.01.021 · Cited by 78
Penetratin Derivative-Based Nanocomplexes for Enhanced Intestinal Insulin Delivery
Zhu, X. D., Shan, W., Zhang, P., Jin, Y., Guan, S., Fan, T., Yang, Y., Zhou, Z., & Huang, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400493b · Cited by 78
Meynell, H. M., Thomas, N. W., James, P. S., Holland, J., Taussig, M., & Nicoletti, C. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.6.611 · Cited by 76
Vong, L. B., Mo, J., Abrahamsson, B., & Nagasaki, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.275 · Cited by 71
Gelberg, H. B. (2014) · Toxicologic Pathology · doi:10.1177/0192623313518113 · Cited by 68
Tamagawa, H., Takahashi, I., Furuse, M., Yoshitake-Kitano, Y., Tsukita, S., Ito, T., Matsuda, H., & Kiyono, H. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000078741.55670.6e · Cited by 67
Leonard, F. (2012) · ALTEX · doi:10.14573/altex.2012.3.275 · Cited by 64
Nanoparticle Transport in Epithelial Cells: Pathway Switching Through Bioconjugation
Fowler, R., Vllasaliu, D., Fernández‐Trillo, F., Garnett, M. C., Alexander, C., Horsley, H. T., Smith, B., Whitcombe, I. W. A., Eaton, M., & Stolnik, S. (2013) · Small · doi:10.1002/smll.201202623 · Cited by 64
de Sousa, I. P., Moser, T., Steiner, C., Fichtl, B., & Bernkop‐Schnürch, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.022 · Cited by 62
Targeted Delivery of Drugs to the Gastrointestinal Tract
Lavelle, E. C. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i4.10 · Cited by 55
Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles
Vong, L. B., & Nagasaki, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00676 · Cited by 55
ElKasabgy, N. A., Elsayed, I., & Elshafeey, A. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.06.048 · Cited by 53
In vitro cell and tissue models for studying host–microbe interactions: a review
Bermúdez-Brito, M., Plaza‐Díaz, J., Fontana, L., Muñoz‐Quezada, S., & Gil, Á. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512004023 · Cited by 53
VB12-coated Gel-Core-SLN containing insulin: Another way to improve oral absorption
He, H., Wang, P., Cai, C., Yang, R., & Tang, X. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.004 · Cited by 52
Gastroretentive Drug Delivery Systems for Therapeutic Management of Peptic Ulcer
Garg, T., Kumar, A., Rath, G., & Goyal, A. K. (2014) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2014011104 · Cited by 51
Biological therapy for ulcerative colitis
Arora, Z., & Shen, B. (2014) · Gastroenterology report · doi:10.1093/gastro/gou070 · Cited by 51
Deng, L., Dong, H., Dong, A., & Zhang, J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.10.010 · Cited by 50
A novel ligand conjugated nanoparticles for oral insulin delivery
Liu, C., Shan, W., Liu, M., Zhu, X. D., Xu, J., Xu, Y., & Huang, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1058433 · Cited by 49
Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter?
Hinkley, G. K., Carpinone, P. L., Munson, J. W., Powers, K. W., & Roberts, S. M. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-015-0085-5 · Cited by 49
Ethyl cellulose nanoparticles: Clarithomycin encapsulation and eradication of H. pylori
Pan-In, P., Banlunara, W., Chaichanawongsaroj, N., & Wanichwecharungruang, S. P. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.025 · Cited by 48
Thornton, S. J., & Wasan, K. M. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902802861 · Cited by 48
Particle uptake and translocation across epithelial membranes.
Thomas, N. W., Jenkins, P. G., Howard, K. A., Mw, S., Lavelle, E. C., Holland, J., & Davis, S. S. (1996) · Europe PMC (PubMed Central) · Cited by 47
The transport mechanism of integrin α v β 3 receptor targeting nanoparticles in Caco-2 cells
Xu, Y., Xu, J., Shan, W., Liu, M., Cui, Y., Li, L., Liu, C., & Huang, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.028 · Cited by 47
Cell Cultures in Drug Discovery: An Industrial Perspective
Ungell, A.-L. B., & Karlsson, J. E. (2003) · Methods and principles in medicinal chemistry · doi:10.1002/3527601473.ch5 · Cited by 43
Li, X., Wang, C., Liang, R., Sun, F., Shi, Y., Wang, A., Liu, W., Sun, K., & Li, Y. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1513-1 · Cited by 43
Gastroretentive microparticles for drug delivery applications
Adebisi, A. O., & Conway, B. R. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.590613 · Cited by 43
Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery
Canevari, M., Castagliuolo, I., Brun, P., Cardin, M., Schiavon, M., Pasut, G., & Veronese, F. M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.058 · Cited by 42
Mucin Multilayers Assembled through Sugar–Lectin Interactions
Crouzier, T., Beckwitt, C. H., & Ribbeck, K. (2012) · Biomacromolecules · doi:10.1021/bm301222f · Cited by 40
Lambkin, I., Pinilla, C., Hamashin, C., Spindler, L., Russell, S., Schink, A., Moya-Castro, R., Allicotti, G., Higgins, L., Smith, M., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1025061317400 · Cited by 39
Vong, L. B., Yoshitomi, T., Morikawa, K., Saito, S., Matsui, H., & Nagasaki, Y. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0836-8 · Cited by 39
Nassar, T., Attili-Qadri, S., Harush-Frenkel, O., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3118 · Cited by 35
The gut wall provides an effective barrier against nanoparticle uptake
Sinnecker, H., Krause, T., Koelling, S., Lautenschläger, I., & Frey, A. (2014) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.5.218 · Cited by 34
Siram, K., Raghavan, C. V., Natarajan, T., Balakumar, K., Ebrahim, H. R. M., Karanam, V., Muthuswamy, S. S. K., & Ranganathan, H. P. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.915310 · Cited by 33
Xia, D., Tao, J., He, Y., Zhu, Q., Chen, D., Yu, M., Cui, F., & Gan, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.038 · Cited by 29
Wolk, O., Epstein, S., Ioffe, V., Ben‐Shabat, S., & Dahan, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.800480 · Cited by 26
Nanotechnology in drug delivery: the need for more cell culture based studies in screening
Kura, A. U., Fakurazi, S., Hussein, M. Z., & Arulselvan, P. (2014) · Chemistry Central Journal · doi:10.1186/1752-153x-8-46 · Cited by 26
Russell-Jones, G. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.129 · Cited by 23
Modification of Drug Delivery to Improve Antibiotic Targeting to the Stomach
Adebisi, A. O., & Conway, B. R. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.35 · Cited by 19
Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems
Hartman, K. G., Bortner, J. D., Falk, G. W., Ginsberg, G. G., Jhala, N. C., Yu, J., Martín, M. G., Rustgi, A. K., & Lynch, J. P. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214529388 · Cited by 19
Ruiz, J. F. M., Kędziora, K., Windle, H. J., Kelleher, D. P., & Gilmer, J. F. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01289.x · Cited by 14
The promise of organotypic hepatic and gastrointestinal models
Vu, L. T., Less, R. R., & Rajagopalan, P. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.04.006 · Cited by 12
Tachaprutinun, A., Pan-In, P., Samutprasert, P., Banlunara, W., Chaichanawongsaroj, N., & Wanichwecharungruang, S. P. (2014) · Biomacromolecules · doi:10.1021/bm5012618 · Cited by 9
Barzegar-Jalali, M., Mohammadi, K., Mohammadi, G., Valizadeh, H., Barzegar-Jalali, A., Adibkia, K., & Nokhodchi, A. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3np5n · Cited by 8
β-Glucuronidase activity in germ-free, monoassociated and conventional mice
Cardona, M. E., Norin, E. L., & Midtvedt, T. (2006) · Microbial Ecology in Health and Disease · doi:10.1080/08910600600733264 · Cited by 5
β-Glucuronidase activity in germ-free, monoassociated and conventional mice
Cardona, M. E., Norin, E. L., & Midtvedt, T. (2006) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v18i1.7698 · Cited by 4
Cited by
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
M. Ways, T., Lau, W., & Khutoryanskiy, V. (2018) · Polymers · doi:10.3390/polym10030267 · Cited by 908
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Lundquist, P., & Artursson, P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.007 · Cited by 483
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
Kou, L., Bhutia, Y. D., Yao, Q., He, Z., Sun, J., & Ganapathy, V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00027 · Cited by 308
Metadata
- Authors
- Date, A. A., Hanes, J., & Ensign, L. M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 240
- Pages
- 504-526
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2414365196
- Cited by
- 539
- References
- 190
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.